Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs
- 18 June 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 199 (1), 51-59
- https://doi.org/10.1016/0014-2999(91)90636-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisBiochemical and Biophysical Research Communications, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990
- Pressor effect of NG-nitro-L-arginine in pentobarbital-anesthetized ratsLife Sciences, 1990
- L-arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivoBiochemical and Biophysical Research Communications, 1989
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980